nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—ABCB1—Topotecan—cervical cancer	0.145	0.625	CbGbCtD
Risperidone—CYP3A4—Topotecan—cervical cancer	0.0869	0.375	CbGbCtD
Risperidone—H1F0—semen—cervical cancer	0.0374	0.123	CbGeAlD
Risperidone—Bullous eruption—Topotecan—cervical cancer	0.0113	0.057	CcSEcCtD
Risperidone—H1F0—uterine cervix—cervical cancer	0.00682	0.0224	CbGeAlD
Risperidone—ADRA1B—renal system—cervical cancer	0.00676	0.0222	CbGeAlD
Risperidone—Intestinal obstruction—Topotecan—cervical cancer	0.00654	0.0331	CcSEcCtD
Risperidone—H1F0—decidua—cervical cancer	0.0065	0.0214	CbGeAlD
Risperidone—H1F0—renal system—cervical cancer	0.00638	0.021	CbGeAlD
Risperidone—H1F0—endometrium—cervical cancer	0.00617	0.0203	CbGeAlD
Risperidone—H1F0—mammalian vulva—cervical cancer	0.00597	0.0196	CbGeAlD
Risperidone—Rash erythematous—Topotecan—cervical cancer	0.00582	0.0294	CcSEcCtD
Risperidone—H1F0—uterus—cervical cancer	0.00569	0.0187	CbGeAlD
Risperidone—Rigors—Topotecan—cervical cancer	0.00546	0.0276	CcSEcCtD
Risperidone—H1F0—female reproductive system—cervical cancer	0.00511	0.0168	CbGeAlD
Risperidone—HTR2B—uterine cervix—cervical cancer	0.00492	0.0162	CbGeAlD
Risperidone—Hyperbilirubinaemia—Topotecan—cervical cancer	0.0049	0.0248	CcSEcCtD
Risperidone—Dysmenorrhoea—Topotecan—cervical cancer	0.0049	0.0248	CcSEcCtD
Risperidone—HTR2B—decidua—cervical cancer	0.00468	0.0154	CbGeAlD
Risperidone—Bone pain—Topotecan—cervical cancer	0.00465	0.0235	CcSEcCtD
Risperidone—H1F0—female gonad—cervical cancer	0.00465	0.0153	CbGeAlD
Risperidone—H1F0—vagina—cervical cancer	0.00462	0.0152	CbGeAlD
Risperidone—Pulmonary embolism—Topotecan—cervical cancer	0.00446	0.0225	CcSEcCtD
Risperidone—HTR2B—endometrium—cervical cancer	0.00445	0.0146	CbGeAlD
Risperidone—Colitis—Topotecan—cervical cancer	0.00428	0.0216	CcSEcCtD
Risperidone—HTR7—epithelium—cervical cancer	0.00425	0.014	CbGeAlD
Risperidone—HTR1A—renal system—cervical cancer	0.00412	0.0136	CbGeAlD
Risperidone—HTR2B—uterus—cervical cancer	0.0041	0.0135	CbGeAlD
Risperidone—ADRA1A—epithelium—cervical cancer	0.00409	0.0135	CbGeAlD
Risperidone—HTR1B—female reproductive system—cervical cancer	0.00409	0.0135	CbGeAlD
Risperidone—Rash maculo-papular—Topotecan—cervical cancer	0.00405	0.0205	CcSEcCtD
Risperidone—Neoplasm—Topotecan—cervical cancer	0.00403	0.0204	CcSEcCtD
Risperidone—HTR1D—female reproductive system—cervical cancer	0.00396	0.013	CbGeAlD
Risperidone—HTR7—renal system—cervical cancer	0.00394	0.013	CbGeAlD
Risperidone—KCNH2—uterine cervix—cervical cancer	0.00392	0.0129	CbGeAlD
Risperidone—HTR2C—female reproductive system—cervical cancer	0.00392	0.0129	CbGeAlD
Risperidone—Sepsis—Topotecan—cervical cancer	0.00387	0.0196	CcSEcCtD
Risperidone—ADRA2C—uterine cervix—cervical cancer	0.00387	0.0127	CbGeAlD
Risperidone—ADRA1A—renal system—cervical cancer	0.0038	0.0125	CbGeAlD
Risperidone—Ear pain—Topotecan—cervical cancer	0.00379	0.0192	CcSEcCtD
Risperidone—ADRA2C—decidua—cervical cancer	0.00369	0.0121	CbGeAlD
Risperidone—HTR2B—female reproductive system—cervical cancer	0.00368	0.0121	CbGeAlD
Risperidone—KCNH2—renal system—cervical cancer	0.00367	0.0121	CbGeAlD
Risperidone—ADRA2C—renal system—cervical cancer	0.00362	0.0119	CbGeAlD
Risperidone—KCNH2—endometrium—cervical cancer	0.00355	0.0117	CbGeAlD
Risperidone—ADRA2C—endometrium—cervical cancer	0.0035	0.0115	CbGeAlD
Risperidone—Dermatitis bullous—Topotecan—cervical cancer	0.00339	0.0171	CcSEcCtD
Risperidone—ADRA2C—mammalian vulva—cervical cancer	0.00338	0.0111	CbGeAlD
Risperidone—Anaphylactoid reaction—Topotecan—cervical cancer	0.00334	0.0169	CcSEcCtD
Risperidone—HTR2B—vagina—cervical cancer	0.00333	0.011	CbGeAlD
Risperidone—Lethargy—Topotecan—cervical cancer	0.0033	0.0167	CcSEcCtD
Risperidone—KCNH2—uterus—cervical cancer	0.00327	0.0108	CbGeAlD
Risperidone—CYP3A5—uterine cervix—cervical cancer	0.00324	0.0107	CbGeAlD
Risperidone—ADRA2C—uterus—cervical cancer	0.00322	0.0106	CbGeAlD
Risperidone—HRH1—epithelium—cervical cancer	0.00317	0.0104	CbGeAlD
Risperidone—HTR7—female reproductive system—cervical cancer	0.00315	0.0104	CbGeAlD
Risperidone—HRH1—uterine cervix—cervical cancer	0.00314	0.0103	CbGeAlD
Risperidone—ADRA2A—uterine cervix—cervical cancer	0.00309	0.0102	CbGeAlD
Risperidone—Cardiac arrest—Topotecan—cervical cancer	0.00308	0.0156	CcSEcCtD
Risperidone—CYP3A5—renal system—cervical cancer	0.00303	0.00997	CbGeAlD
Risperidone—HRH1—decidua—cervical cancer	0.00299	0.00985	CbGeAlD
Risperidone—H1F0—lymph node—cervical cancer	0.00299	0.00984	CbGeAlD
Risperidone—ADRA2A—decidua—cervical cancer	0.00294	0.00968	CbGeAlD
Risperidone—KCNH2—female reproductive system—cervical cancer	0.00294	0.00966	CbGeAlD
Risperidone—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.00291	0.0147	CcSEcCtD
Risperidone—Alanine aminotransferase increased—Topotecan—cervical cancer	0.00285	0.0144	CcSEcCtD
Risperidone—HRH1—endometrium—cervical cancer	0.00284	0.00935	CbGeAlD
Risperidone—ADRA2A—endometrium—cervical cancer	0.00279	0.00919	CbGeAlD
Risperidone—HRH1—mammalian vulva—cervical cancer	0.00275	0.00905	CbGeAlD
Risperidone—ADRA2A—mammalian vulva—cervical cancer	0.0027	0.00888	CbGeAlD
Risperidone—KCNH2—female gonad—cervical cancer	0.00267	0.00879	CbGeAlD
Risperidone—KCNH2—vagina—cervical cancer	0.00266	0.00874	CbGeAlD
Risperidone—HTR2A—epithelium—cervical cancer	0.00265	0.00871	CbGeAlD
Risperidone—ADRA2C—female gonad—cervical cancer	0.00264	0.00868	CbGeAlD
Risperidone—ADRA2C—vagina—cervical cancer	0.00262	0.00862	CbGeAlD
Risperidone—Neutropenia—Topotecan—cervical cancer	0.00262	0.0132	CcSEcCtD
Risperidone—ADRA2A—uterus—cervical cancer	0.00257	0.00846	CbGeAlD
Risperidone—Weight increased—Topotecan—cervical cancer	0.00255	0.0129	CcSEcCtD
Risperidone—Pneumonia—Topotecan—cervical cancer	0.00251	0.0127	CcSEcCtD
Risperidone—Infestation—Topotecan—cervical cancer	0.00249	0.0126	CcSEcCtD
Risperidone—Infestation NOS—Topotecan—cervical cancer	0.00249	0.0126	CcSEcCtD
Risperidone—HTR2A—renal system—cervical cancer	0.00246	0.00808	CbGeAlD
Risperidone—Neuropathy peripheral—Topotecan—cervical cancer	0.00244	0.0124	CcSEcCtD
Risperidone—Stomatitis—Topotecan—cervical cancer	0.00243	0.0123	CcSEcCtD
Risperidone—Sweating—Topotecan—cervical cancer	0.00239	0.0121	CcSEcCtD
Risperidone—Hepatobiliary disease—Topotecan—cervical cancer	0.00236	0.0119	CcSEcCtD
Risperidone—HRH1—female reproductive system—cervical cancer	0.00235	0.00775	CbGeAlD
Risperidone—Epistaxis—Topotecan—cervical cancer	0.00235	0.0119	CcSEcCtD
Risperidone—ADRA2A—female reproductive system—cervical cancer	0.00231	0.00761	CbGeAlD
Risperidone—CYP3A4—renal system—cervical cancer	0.00227	0.00748	CbGeAlD
Risperidone—Haemoglobin—Topotecan—cervical cancer	0.00225	0.0114	CcSEcCtD
Risperidone—Rhinitis—Topotecan—cervical cancer	0.00224	0.0114	CcSEcCtD
Risperidone—Haemorrhage—Topotecan—cervical cancer	0.00224	0.0113	CcSEcCtD
Risperidone—CYP2D6—renal system—cervical cancer	0.00224	0.00736	CbGeAlD
Risperidone—Hypoaesthesia—Topotecan—cervical cancer	0.00223	0.0113	CcSEcCtD
Risperidone—Pharyngitis—Topotecan—cervical cancer	0.00222	0.0112	CcSEcCtD
Risperidone—CYP3A5—female gonad—cervical cancer	0.00221	0.00726	CbGeAlD
Risperidone—CYP3A5—vagina—cervical cancer	0.00219	0.00722	CbGeAlD
Risperidone—HTR2B—lymph node—cervical cancer	0.00215	0.00709	CbGeAlD
Risperidone—HRH1—female gonad—cervical cancer	0.00214	0.00705	CbGeAlD
Risperidone—HRH1—vagina—cervical cancer	0.00213	0.00701	CbGeAlD
Risperidone—ADRA2A—female gonad—cervical cancer	0.0021	0.00692	CbGeAlD
Risperidone—ADRA2A—vagina—cervical cancer	0.00209	0.00688	CbGeAlD
Risperidone—Angiopathy—Topotecan—cervical cancer	0.00203	0.0103	CcSEcCtD
Risperidone—Immune system disorder—Topotecan—cervical cancer	0.00202	0.0102	CcSEcCtD
Risperidone—Mediastinal disorder—Topotecan—cervical cancer	0.00202	0.0102	CcSEcCtD
Risperidone—Chills—Topotecan—cervical cancer	0.00201	0.0102	CcSEcCtD
Risperidone—Alopecia—Topotecan—cervical cancer	0.00198	0.01	CcSEcCtD
Risperidone—HTR2A—female reproductive system—cervical cancer	0.00197	0.00647	CbGeAlD
Risperidone—Malnutrition—Topotecan—cervical cancer	0.00195	0.00986	CcSEcCtD
Risperidone—Back pain—Topotecan—cervical cancer	0.00189	0.00953	CcSEcCtD
Risperidone—Muscle spasms—Topotecan—cervical cancer	0.00187	0.00948	CcSEcCtD
Risperidone—CYP3A4—female reproductive system—cervical cancer	0.00182	0.00599	CbGeAlD
Risperidone—Ill-defined disorder—Topotecan—cervical cancer	0.00181	0.00915	CcSEcCtD
Risperidone—Anaemia—Topotecan—cervical cancer	0.0018	0.00911	CcSEcCtD
Risperidone—CYP2D6—female reproductive system—cervical cancer	0.00179	0.00589	CbGeAlD
Risperidone—Angioedema—Topotecan—cervical cancer	0.00178	0.00901	CcSEcCtD
Risperidone—HTR2A—vagina—cervical cancer	0.00178	0.00585	CbGeAlD
Risperidone—Malaise—Topotecan—cervical cancer	0.00176	0.00889	CcSEcCtD
Risperidone—Leukopenia—Topotecan—cervical cancer	0.00174	0.00882	CcSEcCtD
Risperidone—ABCB1—epithelium—cervical cancer	0.00173	0.00571	CbGeAlD
Risperidone—ABCB1—uterine cervix—cervical cancer	0.00172	0.00566	CbGeAlD
Risperidone—KCNH2—lymph node—cervical cancer	0.00172	0.00565	CbGeAlD
Risperidone—Cough—Topotecan—cervical cancer	0.0017	0.0086	CcSEcCtD
Risperidone—ADRA2C—lymph node—cervical cancer	0.0017	0.00558	CbGeAlD
Risperidone—Arthralgia—Topotecan—cervical cancer	0.00166	0.00839	CcSEcCtD
Risperidone—Myalgia—Topotecan—cervical cancer	0.00166	0.00839	CcSEcCtD
Risperidone—Chest pain—Topotecan—cervical cancer	0.00166	0.00839	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00165	0.00833	CcSEcCtD
Risperidone—Discomfort—Topotecan—cervical cancer	0.00164	0.00829	CcSEcCtD
Risperidone—ABCB1—decidua—cervical cancer	0.00164	0.00539	CbGeAlD
Risperidone—CYP2D6—female gonad—cervical cancer	0.00163	0.00536	CbGeAlD
Risperidone—ABCB1—renal system—cervical cancer	0.00161	0.00529	CbGeAlD
Risperidone—Anaphylactic shock—Topotecan—cervical cancer	0.00159	0.00804	CcSEcCtD
Risperidone—Infection—Topotecan—cervical cancer	0.00158	0.00799	CcSEcCtD
Risperidone—Nervous system disorder—Topotecan—cervical cancer	0.00156	0.00789	CcSEcCtD
Risperidone—Thrombocytopenia—Topotecan—cervical cancer	0.00156	0.00788	CcSEcCtD
Risperidone—ABCB1—endometrium—cervical cancer	0.00156	0.00512	CbGeAlD
Risperidone—Skin disorder—Topotecan—cervical cancer	0.00154	0.00781	CcSEcCtD
Risperidone—Hyperhidrosis—Topotecan—cervical cancer	0.00154	0.00778	CcSEcCtD
Risperidone—Anorexia—Topotecan—cervical cancer	0.00152	0.00767	CcSEcCtD
Risperidone—ABCB1—mammalian vulva—cervical cancer	0.0015	0.00495	CbGeAlD
Risperidone—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00145	0.00733	CcSEcCtD
Risperidone—ABCB1—uterus—cervical cancer	0.00143	0.00472	CbGeAlD
Risperidone—Paraesthesia—Topotecan—cervical cancer	0.00143	0.00722	CcSEcCtD
Risperidone—Dyspnoea—Topotecan—cervical cancer	0.00142	0.00717	CcSEcCtD
Risperidone—Dyspepsia—Topotecan—cervical cancer	0.0014	0.00708	CcSEcCtD
Risperidone—Decreased appetite—Topotecan—cervical cancer	0.00138	0.00699	CcSEcCtD
Risperidone—HRH1—lymph node—cervical cancer	0.00138	0.00453	CbGeAlD
Risperidone—Gastrointestinal disorder—Topotecan—cervical cancer	0.00137	0.00694	CcSEcCtD
Risperidone—Fatigue—Topotecan—cervical cancer	0.00137	0.00694	CcSEcCtD
Risperidone—Pain—Topotecan—cervical cancer	0.00136	0.00688	CcSEcCtD
Risperidone—Constipation—Topotecan—cervical cancer	0.00136	0.00688	CcSEcCtD
Risperidone—ADRA2A—lymph node—cervical cancer	0.00135	0.00445	CbGeAlD
Risperidone—Feeling abnormal—Topotecan—cervical cancer	0.00131	0.00663	CcSEcCtD
Risperidone—Gastrointestinal pain—Topotecan—cervical cancer	0.0013	0.00658	CcSEcCtD
Risperidone—ABCB1—female reproductive system—cervical cancer	0.00129	0.00424	CbGeAlD
Risperidone—Urticaria—Topotecan—cervical cancer	0.00126	0.00639	CcSEcCtD
Risperidone—Body temperature increased—Topotecan—cervical cancer	0.00126	0.00636	CcSEcCtD
Risperidone—Abdominal pain—Topotecan—cervical cancer	0.00126	0.00636	CcSEcCtD
Risperidone—ABCB1—female gonad—cervical cancer	0.00117	0.00386	CbGeAlD
Risperidone—Hypersensitivity—Topotecan—cervical cancer	0.00117	0.00593	CcSEcCtD
Risperidone—ABCB1—vagina—cervical cancer	0.00117	0.00383	CbGeAlD
Risperidone—Asthenia—Topotecan—cervical cancer	0.00114	0.00577	CcSEcCtD
Risperidone—Pruritus—Topotecan—cervical cancer	0.00113	0.00569	CcSEcCtD
Risperidone—Diarrhoea—Topotecan—cervical cancer	0.00109	0.0055	CcSEcCtD
Risperidone—Dizziness—Topotecan—cervical cancer	0.00105	0.00532	CcSEcCtD
Risperidone—Vomiting—Topotecan—cervical cancer	0.00101	0.00511	CcSEcCtD
Risperidone—Rash—Topotecan—cervical cancer	0.001	0.00507	CcSEcCtD
Risperidone—Dermatitis—Topotecan—cervical cancer	0.001	0.00507	CcSEcCtD
Risperidone—Headache—Topotecan—cervical cancer	0.000996	0.00504	CcSEcCtD
Risperidone—Nausea—Topotecan—cervical cancer	0.000945	0.00478	CcSEcCtD
Risperidone—ABCB1—lymph node—cervical cancer	0.000754	0.00248	CbGeAlD
Risperidone—HTR1A—Signaling Pathways—AKAP13—cervical cancer	0.000136	0.00051	CbGpPWpGaD
Risperidone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000135	0.000508	CbGpPWpGaD
Risperidone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000135	0.000507	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—AKAP13—cervical cancer	0.000135	0.000507	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—WNT5A—cervical cancer	0.000134	0.000505	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—WNT2—cervical cancer	0.000134	0.000501	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—WNT2—cervical cancer	0.000133	0.0005	CbGpPWpGaD
Risperidone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000133	0.000498	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—AKAP13—cervical cancer	0.000131	0.000493	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—WNT2—cervical cancer	0.000131	0.000491	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—AKAP13—cervical cancer	0.000129	0.000485	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—CA9—cervical cancer	0.000126	0.000472	CbGpPWpGaD
Risperidone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000123	0.00046	CbGpPWpGaD
Risperidone—DRD2—Circadian rythm related genes—TP53—cervical cancer	0.000122	0.000458	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—WNT2—cervical cancer	0.000121	0.000456	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—WNT5A—cervical cancer	0.000121	0.000456	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—AKAP13—cervical cancer	0.000119	0.000447	CbGpPWpGaD
Risperidone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000118	0.000444	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—AKAP13—cervical cancer	0.000117	0.00044	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—WNT5A—cervical cancer	0.000117	0.00044	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—AKAP13—cervical cancer	0.000117	0.000439	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—WNT5A—cervical cancer	0.000117	0.000438	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—AKAP13—cervical cancer	0.000115	0.000431	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—WNT5A—cervical cancer	0.000113	0.000426	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—WNT5A—cervical cancer	0.000112	0.000419	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—NOTCH2—cervical cancer	0.000111	0.000417	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—NOTCH2—cervical cancer	0.00011	0.000414	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—NOTCH2—cervical cancer	0.000108	0.000405	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—AKAP13—cervical cancer	0.000107	0.0004	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—NOTCH2—cervical cancer	0.000106	0.000399	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.000103	0.000386	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—NOTCH2—cervical cancer	0.000101	0.000381	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.000101	0.00038	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—WNT5A—cervical cancer	0.000101	0.000379	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—WNT5A—cervical cancer	9.91e-05	0.000372	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—NOTCH2—cervical cancer	9.56e-05	0.000359	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—CA9—cervical cancer	9.49e-05	0.000356	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—NOTCH2—cervical cancer	9.43e-05	0.000354	CbGpPWpGaD
Risperidone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	9.36e-05	0.000352	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	9.21e-05	0.000346	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—HES1—cervical cancer	9.1e-05	0.000342	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—HES1—cervical cancer	9.04e-05	0.000339	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—CA9—cervical cancer	8.94e-05	0.000336	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—HES1—cervical cancer	8.85e-05	0.000332	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—HES1—cervical cancer	8.71e-05	0.000327	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—NOTCH2—cervical cancer	8.52e-05	0.00032	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—HES1—cervical cancer	8.31e-05	0.000312	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	8.22e-05	0.000309	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	8.18e-05	0.000307	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TERT—cervical cancer	7.97e-05	0.000299	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—NOTCH2—cervical cancer	7.95e-05	0.000299	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TERT—cervical cancer	7.92e-05	0.000297	CbGpPWpGaD
Risperidone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	7.86e-05	0.000295	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—HES1—cervical cancer	7.84e-05	0.000294	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—NOTCH2—cervical cancer	7.83e-05	0.000294	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TERT—cervical cancer	7.75e-05	0.000291	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—HES1—cervical cancer	7.73e-05	0.00029	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TERT—cervical cancer	7.63e-05	0.000287	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—FGFR3—cervical cancer	7.31e-05	0.000275	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TERT—cervical cancer	7.28e-05	0.000274	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—FGFR3—cervical cancer	7.27e-05	0.000273	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—NOTCH2—cervical cancer	7.22e-05	0.000271	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—FGFR3—cervical cancer	7.12e-05	0.000267	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	7.1e-05	0.000267	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NOTCH2—cervical cancer	7.09e-05	0.000266	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—MTHFR—cervical cancer	7.06e-05	0.000265	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—FGFR3—cervical cancer	7e-05	0.000263	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—HES1—cervical cancer	6.98e-05	0.000262	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NOTCH2—cervical cancer	6.95e-05	0.000261	CbGpPWpGaD
Risperidone—ADRA2B—Hemostasis—TP53—cervical cancer	6.87e-05	0.000258	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TERT—cervical cancer	6.87e-05	0.000258	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—NOTCH1—cervical cancer	6.87e-05	0.000258	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—MTHFR—cervical cancer	6.85e-05	0.000257	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—NOTCH1—cervical cancer	6.82e-05	0.000256	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TERT—cervical cancer	6.78e-05	0.000254	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—HES1—cervical cancer	6.74e-05	0.000253	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—HES1—cervical cancer	6.71e-05	0.000252	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—FGFR3—cervical cancer	6.68e-05	0.000251	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—NOTCH1—cervical cancer	6.68e-05	0.000251	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—NOTCH1—cervical cancer	6.57e-05	0.000247	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—HES1—cervical cancer	6.52e-05	0.000245	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	6.46e-05	0.000243	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—HES1—cervical cancer	6.42e-05	0.000241	CbGpPWpGaD
Risperidone—ADRA2C—Hemostasis—TP53—cervical cancer	6.42e-05	0.000241	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—FGFR3—cervical cancer	6.3e-05	0.000237	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—NOTCH1—cervical cancer	6.28e-05	0.000236	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—FGFR3—cervical cancer	6.22e-05	0.000234	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TERT—cervical cancer	6.12e-05	0.00023	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—EGFR—cervical cancer	6.12e-05	0.00023	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—EGFR—cervical cancer	6.08e-05	0.000228	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—EGFR—cervical cancer	5.95e-05	0.000223	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—HES1—cervical cancer	5.92e-05	0.000222	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—NOTCH1—cervical cancer	5.92e-05	0.000222	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TERT—cervical cancer	5.91e-05	0.000222	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TERT—cervical cancer	5.88e-05	0.000221	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—EGFR—cervical cancer	5.86e-05	0.00022	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CA9—cervical cancer	5.84e-05	0.000219	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—NOTCH1—cervical cancer	5.84e-05	0.000219	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—HES1—cervical cancer	5.82e-05	0.000219	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—HES1—cervical cancer	5.81e-05	0.000218	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TERT—cervical cancer	5.72e-05	0.000215	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HES1—cervical cancer	5.7e-05	0.000214	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TERT—cervical cancer	5.62e-05	0.000211	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	5.61e-05	0.000211	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—EGFR—cervical cancer	5.59e-05	0.00021	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—MTHFR—cervical cancer	5.57e-05	0.000209	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—FGFR3—cervical cancer	5.42e-05	0.000204	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—FGFR3—cervical cancer	5.39e-05	0.000202	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HES1—cervical cancer	5.3e-05	0.000199	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—EGFR—cervical cancer	5.27e-05	0.000198	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	5.27e-05	0.000198	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—FGFR3—cervical cancer	5.24e-05	0.000197	CbGpPWpGaD
Risperidone—ADRA2A—Hemostasis—TP53—cervical cancer	5.21e-05	0.000196	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—EGFR—cervical cancer	5.2e-05	0.000195	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TERT—cervical cancer	5.19e-05	0.000195	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	5.16e-05	0.000194	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MTOR—cervical cancer	5.15e-05	0.000193	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MTOR—cervical cancer	5.11e-05	0.000192	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TERT—cervical cancer	5.1e-05	0.000192	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—MTHFR—cervical cancer	5.1e-05	0.000192	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TERT—cervical cancer	5.09e-05	0.000191	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	5.09e-05	0.000191	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	5.06e-05	0.00019	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MTOR—cervical cancer	5.01e-05	0.000188	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TERT—cervical cancer	5e-05	0.000188	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MTOR—cervical cancer	4.93e-05	0.000185	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—NOTCH1—cervical cancer	4.92e-05	0.000185	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	4.85e-05	0.000182	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—FGFR3—cervical cancer	4.76e-05	0.000179	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CASP3—cervical cancer	4.73e-05	0.000178	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MTOR—cervical cancer	4.7e-05	0.000177	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CASP3—cervical cancer	4.7e-05	0.000177	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	4.7e-05	0.000176	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—FGFR3—cervical cancer	4.68e-05	0.000176	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—FGFR3—cervical cancer	4.67e-05	0.000175	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TERT—cervical cancer	4.64e-05	0.000174	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CASP3—cervical cancer	4.6e-05	0.000173	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	4.58e-05	0.000172	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—CTNNB1—cervical cancer	4.56e-05	0.000171	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—EGFR—cervical cancer	4.53e-05	0.00017	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—CTNNB1—cervical cancer	4.53e-05	0.00017	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CASP3—cervical cancer	4.53e-05	0.00017	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—EGFR—cervical cancer	4.51e-05	0.000169	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—NOTCH1—cervical cancer	4.47e-05	0.000168	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—CTNNB1—cervical cancer	4.44e-05	0.000167	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MTOR—cervical cancer	4.43e-05	0.000167	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	4.4e-05	0.000165	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—EGFR—cervical cancer	4.39e-05	0.000165	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—NOTCH1—cervical cancer	4.39e-05	0.000165	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MTOR—cervical cancer	4.38e-05	0.000164	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—CTNNB1—cervical cancer	4.37e-05	0.000164	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CASP3—cervical cancer	4.32e-05	0.000162	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	4.32e-05	0.000162	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	4.3e-05	0.000162	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	4.26e-05	0.00016	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—CTNNB1—cervical cancer	4.17e-05	0.000157	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CASP3—cervical cancer	4.08e-05	0.000153	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CASP3—cervical cancer	4.02e-05	0.000151	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	4e-05	0.00015	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—EGFR—cervical cancer	3.98e-05	0.000149	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—STAT3—cervical cancer	3.98e-05	0.000149	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—STAT3—cervical cancer	3.95e-05	0.000148	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MTOR—cervical cancer	3.95e-05	0.000148	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—CTNNB1—cervical cancer	3.93e-05	0.000148	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—EGFR—cervical cancer	3.92e-05	0.000147	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—EGFR—cervical cancer	3.91e-05	0.000147	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—CTNNB1—cervical cancer	3.88e-05	0.000146	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—STAT3—cervical cancer	3.87e-05	0.000145	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—MTHFR—cervical cancer	3.85e-05	0.000145	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	3.84e-05	0.000144	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MTOR—cervical cancer	3.81e-05	0.000143	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—STAT3—cervical cancer	3.81e-05	0.000143	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MTOR—cervical cancer	3.79e-05	0.000142	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MTOR—cervical cancer	3.69e-05	0.000139	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—STAT3—cervical cancer	3.63e-05	0.000136	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CASP3—cervical cancer	3.63e-05	0.000136	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MTOR—cervical cancer	3.63e-05	0.000136	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—MTHFR—cervical cancer	3.63e-05	0.000136	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—EGFR—cervical cancer	3.61e-05	0.000136	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—EGFR—cervical cancer	3.59e-05	0.000135	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	3.56e-05	0.000134	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—EGFR—cervical cancer	3.52e-05	0.000132	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CASP3—cervical cancer	3.51e-05	0.000132	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	3.5e-05	0.000132	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CASP3—cervical cancer	3.49e-05	0.000131	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—EGFR—cervical cancer	3.46e-05	0.00013	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—STAT3—cervical cancer	3.43e-05	0.000129	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CASP3—cervical cancer	3.39e-05	0.000127	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—STAT3—cervical cancer	3.38e-05	0.000127	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	3.38e-05	0.000127	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	3.36e-05	0.000126	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MTOR—cervical cancer	3.35e-05	0.000126	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CASP3—cervical cancer	3.34e-05	0.000125	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—EGFR—cervical cancer	3.3e-05	0.000124	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MTOR—cervical cancer	3.29e-05	0.000124	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MTOR—cervical cancer	3.29e-05	0.000123	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CTNNB1—cervical cancer	3.27e-05	0.000123	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MTOR—cervical cancer	3.23e-05	0.000121	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	3.22e-05	0.000121	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—EGFR—cervical cancer	3.11e-05	0.000117	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CASP3—cervical cancer	3.08e-05	0.000116	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—EGFR—cervical cancer	3.07e-05	0.000115	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—STAT3—cervical cancer	3.05e-05	0.000115	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TP53—cervical cancer	3.03e-05	0.000114	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CASP3—cervical cancer	3.03e-05	0.000114	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CASP3—cervical cancer	3.02e-05	0.000114	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TP53—cervical cancer	3.01e-05	0.000113	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MTOR—cervical cancer	3e-05	0.000113	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CTNNB1—cervical cancer	2.97e-05	0.000111	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CASP3—cervical cancer	2.97e-05	0.000111	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—cervical cancer	2.95e-05	0.000111	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—STAT3—cervical cancer	2.95e-05	0.000111	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—STAT3—cervical cancer	2.93e-05	0.00011	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	2.92e-05	0.00011	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CTNNB1—cervical cancer	2.91e-05	0.000109	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—cervical cancer	2.9e-05	0.000109	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	2.86e-05	0.000107	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—STAT3—cervical cancer	2.85e-05	0.000107	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—STAT3—cervical cancer	2.81e-05	0.000105	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—EGFR—cervical cancer	2.77e-05	0.000104	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—cervical cancer	2.77e-05	0.000104	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CASP3—cervical cancer	2.76e-05	0.000104	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—EGFR—cervical cancer	2.68e-05	0.000101	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—EGFR—cervical cancer	2.66e-05	0.0001	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	2.66e-05	9.98e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—cervical cancer	2.62e-05	9.82e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—EGFR—cervical cancer	2.59e-05	9.73e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—STAT3—cervical cancer	2.59e-05	9.72e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—cervical cancer	2.58e-05	9.69e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—EGFR—cervical cancer	2.55e-05	9.58e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—STAT3—cervical cancer	2.55e-05	9.56e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—STAT3—cervical cancer	2.54e-05	9.54e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—STAT3—cervical cancer	2.49e-05	9.36e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—MTHFR—cervical cancer	2.37e-05	8.91e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—EGFR—cervical cancer	2.35e-05	8.83e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—cervical cancer	2.33e-05	8.75e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—STAT3—cervical cancer	2.32e-05	8.7e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—EGFR—cervical cancer	2.31e-05	8.69e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—EGFR—cervical cancer	2.31e-05	8.67e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—EGFR—cervical cancer	2.27e-05	8.51e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—cervical cancer	2.25e-05	8.44e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—cervical cancer	2.24e-05	8.4e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—cervical cancer	2.18e-05	8.17e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—cervical cancer	2.14e-05	8.04e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—EGFR—cervical cancer	2.1e-05	7.9e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—cervical cancer	1.97e-05	7.41e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—cervical cancer	1.94e-05	7.3e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—cervical cancer	1.94e-05	7.28e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—cervical cancer	1.9e-05	7.14e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—cervical cancer	1.77e-05	6.64e-05	CbGpPWpGaD
